<SEC-DOCUMENT>0001104659-19-077405-index.html : 20191231
<SEC-HEADER>0001104659-19-077405.hdr.sgml : 20191231
<ACCEPTANCE-DATETIME>20191231191100
ACCESSION NUMBER:		0001104659-19-077405
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20191227
FILED AS OF DATE:		20191231
DATE AS OF CHANGE:		20191231

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Versant Venture Capital VI, L.P.
		CENTRAL INDEX KEY:			0001687880
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38944
		FILM NUMBER:		191320344

	BUSINESS ADDRESS:	
		STREET 1:		ONE SANSOME STREET, SUITE 3630
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104
		BUSINESS PHONE:		(415) 801-8100

	MAIL ADDRESS:	
		STREET 1:		ONE SANSOME STREET, SUITE 3630
		CITY:			SAN FRANCISCO
		STATE:			CA
		ZIP:			94104

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Akero Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001744659
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		170 HARBOR WAY
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		650-487-6488

	MAIL ADDRESS:	
		STREET 1:		170 HARBOR WAY
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>a4a.xml
<DESCRIPTION>4/A
<TEXT>
Document 1 - file: a4a.html

Document 1 - RAW XML: a4a.xml

</DOCUMENT>
</SEC-DOCUMENT>